1. Cell Biology
Download icon

Cancer: A new role for an old enemy

  1. Richard M Monaghan
  2. Alan J Whitmarsh  Is a corresponding author
  1. University of Manchester, United Kingdom
Cite this article as: eLife 2015;4:e06424 doi: 10.7554/eLife.06424
1 figure


AKT, also known as protein kinase B, promotes cancer cell survival in two distinct ways.

AKT (pale green) is recruited to phosphoinositol lipids (purple) at the cell membrane. Normally it is only activated in response to growth or survival signals, but it has increased activity in many cancers. It has been known for some time that AKT promotes the survival of cancer cells by adding phosphate groups (yellow) to protein substrates (light blue): this process involves ATP (not shown) binding to an active site in the kinase domain of the AKT, so it can be inhibited by drugs that compete with ATP to bind to this site (red rectangle). Vivanco, Chen et al. show that AKT can also promote cancer cell survival in a way that is independent of its kinase function: however, the details of this process remain unclear (hence the question mark). Drugs that compete with ATP do not inhibit this kinase-independent role, but allosteric inhibitors (left; see main text) inhibit both the kinase-dependent and kinase-independent roles of AKT, so they have the potential to be more effective therapies to treat cancer.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)